To date, there remains just one drug approved for stroke intervention, tissue plasminogen activator (tPA), but the use of tPA is limited due to its narrow therapeutic time window of 6 to 8 hours from the onset of ischemic stroke. Here, PLAT is linked to stroke disorder.